semaglutide twice a week US, Japan Patients With Diabetes Discontinue After First Year Messaged provider re: GLP-1 discontinuation

Ask your assigned provider what specific "significant difference" from the commercially available FDA-approved product will be documented in your prescription - this is the legal basis for a 503A compounded prescription under current FDA guidance, and a provider should answer clearly

Compounded GLP-1 medications are not FDA-approved finished drug products and have not been reviewed by the FDA for safety, effectiveness, or quality before marketing

2020;72:e108 Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al

In severe cases, seizures, paralysis, paresthesia, visual changes, and loss of consciousness can occur

VivioMD Reviews and Complaints: What Can Be Verified